Invention Grant
- Patent Title: Bis-benzimidazole derivatives as hepatitis C virus inhibitors
- Patent Title (中): 双苯并咪唑衍生物作为丙型肝炎病毒抑制剂
-
Application No.: US13389277Application Date: 2010-08-06
-
Publication No.: US08623899B2Publication Date: 2014-01-07
- Inventor: David McGowan , Samuel Dominique Demin , Stefaan Julien Last , Koen Vandyck , Pierre Jean-Marie Bernard Raboisson
- Applicant: David McGowan , Samuel Dominique Demin , Stefaan Julien Last , Koen Vandyck , Pierre Jean-Marie Bernard Raboisson
- Applicant Address: IE Little Island, Co Cork
- Assignee: Janssen Research & Development Ireland
- Current Assignee: Janssen Research & Development Ireland
- Current Assignee Address: IE Little Island, Co Cork
- Priority: EP09167436 20090807
- International Application: PCT/EP2010/061494 WO 20100806
- International Announcement: WO2011/015658 WO 20110210
- Main IPC: A61K31/4184
- IPC: A61K31/4184 ; C07D403/10
Abstract:
Inhibitors of HCV replication of formula I including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R′ have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in HCV therapy.
Public/Granted literature
- US20120135953A1 Bis-Benzimidazole Derivatives As Hepatitis C Virus Inhibitors Public/Granted day:2012-05-31
Information query
IPC分类:
